Get 20% lifetime commission for referring investors to digrin.com
here.
Revance Therapeutics, Inc. (RVNC) Financials
Stock symbol RVNC is outdated, potentially delisted? Maybe it is available on other exchange?
RVNC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 461.6 million | 624.6 million |
| June 30, 2024 | 494.8 million | 624.5 million |
| March 31, 2024 | 508.1 million | 606.8 million |
| Dec. 31, 2023 | 478.5 million | 630.1 million |
RVNC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -41.2 million | 4.6 million |
| June 30, 2024 | -41.6 million | 5.8 million |
| March 31, 2024 | -67.7 million | 9.0 million |
| Dec. 31, 2023 | -44.5 million | 8.8 million |
RVNC Net Income
No data available :(
RVNC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 184.1 million | 456.1 million | - |
| June 30, 2024 | 232.5 million | 460.0 million | 61.1 million |
| March 31, 2024 | 277.6 million | 463.7 million | 45.9 million |
| Dec. 31, 2023 | 254.5 million | 467.6 million | 49.3 million |
RVNC Shares Outstanding
RVNC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 61000 | 11.4 million | 62.6 million | - |
| June 30, 2024 | 470000 | 15.5 million | 65.4 million | 123000 |
| March 31, 2024 | 1.7 million | 13.6 million | 67.5 million | - |
| Dec. 31, 2023 | 1.8 million | 19.7 million | 84.3 million | 253.4 million |
RVNC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 58.8 million | 17.6 million |
| June 30, 2024 | 65.4 million | 19.1 million |
| March 31, 2024 | 51.9 million | 16.9 million |
| Dec. 31, 2023 | 69.8 million | 18.9 million |
RVNC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RVNC
Price: $3.65
52 week price:
Earnings Per Share: -3.34 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 728800
Ebitda: -30.2 millionMarket Capitalization: 381.0 million